Earnings
EpiCept 3Q Loss Narrows On Lower Costs
TARRYTOWN, N.Y. (AP) — Drug company EpiCept Corp. said Tuesday its third-quarter loss narrowed on lower selling, general, and administrative expenses.
The company lost $4.8 million, or 4 cents per share, compared with a loss of $6.2 million, or 9 cents per share, during the same period a year prior. Revenue rose 49 percent to $116,000 from $78,000. Operating expenses fell 6 percent to $5.1 million, mainly from lower non-cash compensation, lender fees and legal fees. Also, the company gained $268,000 from foreign currency exchange rates. EpiCept's lead product candidate is Ceplene, aimed at treatment and relapse prevention of adult patients with leukemia. Shares of EpiCept fell 7 cents, or 8.5 percent, to 75 cents in afternoon trading. Shares have traded between 42 cents and $1.25 over the past 52 weeks.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |
Connect with TheStreet